Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 40.01 USD 1.57%
Market Cap: 15.4B USD
Have any thoughts about
Moderna Inc?
Write Note

P/E
Price to Earnings

-6.9
Current
3.9
Median
22.1
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-6.9
=
Market Cap
15.1B USD
/
Net Income
-2.2B USD
All Countries
Close
Earnings Growth P/E to Growth
US
Moderna Inc
NASDAQ:MRNA
Average P/E: 210.6
Negative Multiple: -6.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
910
77%
11.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -211.2
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-4.1
2-Years Forward
P/E
-4.3
3-Years Forward
P/E
-5.7

See Also

Discover More